Products

Primary tabs

Export products to Excel

Displaying 1 - 15 of 17
Alternative Name: SILCS Diaphragm
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Non-hormonal
Delivery Type: Barrier
Project Stage: Marketed
Alternative Name: l’Amour®, Jeitosa®
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Non-hormonal
Delivery Type: Barrier
Project Stage: Marketed
Partner: Cupid Ltd.
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Hormonal
Delivery Type: Oral
Project Stage: Marketed
Partner: HRA Pharma
Alternative Name: FC-Patch low, Lisvy®
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Regulatory
Alternative Name: GyneFix 330
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Non-hormonal
Delivery Type: Intrauterine
Project Stage: Marketed
Alternative Name: SCu300 Intrauterine Devices
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Non-hormonal
Delivery Type: Intrauterine
Project Stage: Marketed
Alternative Name: LNG Contraceptive IUS (LCS), LCS16
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Marketed
Partner: Bayer HealthCare
Alternative Name: Smaller/Nulliparous Copper IUD
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Non-hormonal
Delivery Type: Intrauterine
Project Stage: Marketed
Alternative Name: Levosert (U.K.), Erlacela (Portugal), Donasert (Romania)
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Marketed
Partner: Actavis, Medicines360
Alternative Name: Woman's Condom (WC)
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Non-hormonal
Delivery Type: Barrier
Project Stage: Marketed
Alternative Name: VA w.o.w.
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Non-hormonal
Delivery Type: Barrier
Project Stage: Marketed
Alternative Name: Depo-subQ + Uniject
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Marketed
Partner: Pfizer, PATH, USAID
Alternative Name: Zarin, Femplant, Trust
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Marketed
Export to Excel